Hematology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Thrombosis
Volcano Corporation Reports Use of IVUS Increasing as Physicians Refocus on Stent Technique
April 16th, 2007
Volcano Corporation (NASDAQ:VOLC) today summarized the role of Intravascular Ultrasound (IVUS) in a shifting Drug Eluting Stent (DES) market. Use of DES has decreased from 89% of PCIs in the U.S. down to an estimated 70% over the past year, driven by concerns over stent thrombosis causing heart attacks, and confidence in Bare Metal Stent (BMS) safety. In the same period, Volcano has seen an increase of 25% in IVUS revenue, demonstrating more reliance on detailed imaging to guide optimal DES and BMS placement. Martin B. Leon, M.D., of Columbia University Medical Center and the Cardiovascular Research Foundation, New York commented, "The negative press around acute and...
Source: Hematology Week (2007-04-16)
|
